Exchange: NASDAQ·Updated 07:30 PM EDT

CLLS News

News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLSPR NewswireNEW YORK, Sept. 24, 2026 NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLSPR NewswireNEW YORK, Sept. 24, 2026 NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
More News
CLLS Investors Have Opportunity to Join Cellectis S.A. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cellectis S.A. (Cellectis or the Company) (NASDAQ: CLLS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on...
Business Wire
Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cellectis S.A. (Cellectis or the Company) (NASDAQ: CLLS) investors concerning the Companys possible violations of the federal securities laws. IF...
Business Wire
Cellectis S.A. (CLLS) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Cellectis S.A. (Cellectis or the Company) (NASDAQ: CLLS) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CELLECTIS S.A. (CLLS), CONTACT THE LAW...
Business Wire
Securities Fraud Investigation Into Cellectis S.A. (CLLS) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Cellectis S.A. (Cellectis or the Company) (NASDAQ: CLLS) on behalf of investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON CELLECTIS S.A. (CLLS), CLICK HERE TO INQUIRE...
Business Wire
This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Banco Santander Brasil, Ribbon Communications, Cellectis, Scholar Rock, with mixed price-target changes.read more...
Benzinga
CLLS Stock Heads For 14-Month Low After 40% Rout: Citizens Flags Delayed Cellectis Catalysts After Cancer Pipeline Pivot
Cellectis received a downgrade after pivoting to cardiovascular diseases therapy from a type of cancer therapy
Stocktwits
Cellectis Pivots to Gene Editing in Major Overhaul
Cellectis (NASDAQ: CLLS) pivots to in vivo gene editing, extending cash runway to H2 2028. Read pipeline updates on .HEAL-101 & .HEAL-201.read more...
Benzinga
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.read more...
Benzinga
CLLS Stock Rallies Over 24% After Hours — Here's Why
FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to Cellectis’s investigational cell therapy.
Stocktwits

Advertisement|Remove ads.